The Lighthouse Tenofovir Cohort Study

• Status: Unknown status
• Trial end date: 2018-07-01
• Target enrollment: 0
• Participant gender: All

Summary

Lighthouse, in cooperation with the University Heidelberg Public Health Institute and the University Köln (Cologne) would like to set up a cohort to study baseline characteristics and long-term clinical outcomes of patients using Tenofovir based Antiretroviral Therapy at the Lighthouse. As of March 2014, patients above 18 years and giving informed consent coming to the Lighthouse to newly initiate ART will be approached to enroll in the cohort.

The results will be disseminated both nationally at the Ministry of Health Technical Working Group (TWG), at the annual Research Dissemination and Best Practices conferences of the College of Medicine and National AIDS Commission as well as internationally. The results will also be written up for publication in appropriate peer-reviewed journals.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Lighthouse Trust
• Collaborators: Heidelberg University; Ministry of Health, Malawi; University of Cologne
• Treatments: Tenofovir

Criteria

Inclusion Criteria:

• 18 years or older

• Able and willing to give informed consent